IQCF2
gene geneOn this page
Summary
IQCF2 (IQ motif containing F2, HGNC:31815) is a protein-coding gene on chromosome 3p21.2, encoding IQ domain-containing protein F2 (Q8IXL9).
Predicted to enable calmodulin binding activity.
Source: NCBI Gene 389123 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_203424
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31815 |
| Approved symbol | IQCF2 |
| Name | IQ motif containing F2 |
| Location | 3p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184345 |
| Ensembl biotype | protein_coding |
| Entrez | 389123 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000333127, ENST00000429548
RefSeq mRNA: 1 — MANE Select: NM_203424
NM_203424
CCDS: CCDS2835
Canonical transcript exons
ENST00000333127 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001292527 | 51861615 | 51861684 |
| ENSE00001306247 | 51862987 | 51863424 |
| ENSE00003617121 | 51861858 | 51861950 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 94.83.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0190 / max 20.7499, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36784 | 0.0190 | 3 |
Top tissues by expression
196 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 94.83 | gold quality |
| right testis | UBERON:0004534 | 94.74 | gold quality |
| sperm | CL:0000019 | 93.87 | gold quality |
| testis | UBERON:0000473 | 91.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.92 | gold quality |
| adult organism | UBERON:0007023 | 78.91 | gold quality |
| cartilage tissue | UBERON:0002418 | 60.55 | gold quality |
| myocardium | UBERON:0002349 | 58.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 56.25 | gold quality |
| pancreatic ductal cell | CL:0002079 | 55.24 | silver quality |
| tibialis anterior | UBERON:0001385 | 55.10 | silver quality |
| buccal mucosa cell | CL:0002336 | 55.01 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.07 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| ileal mucosa | UBERON:0000331 | 52.81 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 52.29 | gold quality |
| cerebellar vermis | UBERON:0004720 | 51.71 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 51.13 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.28 | gold quality |
| deltoid | UBERON:0001476 | 50.15 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.35 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 48.96 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 46.96 | gold quality |
| amniotic fluid | UBERON:0000173 | 45.22 | gold quality |
| bronchial epithelial cell | CL:0002328 | 45.06 | gold quality |
| bronchus | UBERON:0002185 | 44.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (4): IQCF1 (ENSG00000173389), IQCF5 (ENSG00000214681), IQCF6 (ENSG00000214686), IQCF3 (ENSG00000229972)
Protein
Protein identifiers
IQ domain-containing protein F2 — Q8IXL9 (reviewed: Q8IXL9)
All UniProt accessions (1): Q8IXL9
RefSeq proteins (1): NP_982248* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR039887 | IQCF | Family |
Pfam: PF00612
UniProt features (3 total): domain 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXL9-F1 | 89.48 | 0.67 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 6 (showing top):
chr3p21, MAFG_TARGET_GENES, TERF2_TARGET_GENES, GSE2706_R848_VS_LPS_2H_STIM_DC_UP, TTCYNRGAA_STAT5B_01, GOMF_CALMODULIN_BINDING
GO Biological Process (0):
GO Molecular Function (2): calmodulin binding (GO:0005516), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
120 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IQCF2 | EFCAB3 | Q8N7B9 | 674 |
| IQCF2 | KRTAP10-11 | P60412 | 444 |
| IQCF2 | HAPLN2 | Q9GZV7 | 414 |
| IQCF2 | SLC13A1 | Q9BZW2 | 390 |
| IQCF2 | KRTAP10-1 | P60331 | 380 |
| IQCF2 | GAGE12B | A1L429 | 357 |
| IQCF2 | POTEG | Q6S5H5 | 349 |
| IQCF2 | XAGE5 | Q8WWM1 | 348 |
| IQCF2 | GSTM5 | P46439 | 321 |
| IQCF2 | PARP3 | Q9Y6F1 | 290 |
| IQCF2 | SLC14A2 | Q15849 | 275 |
| IQCF2 | CFHR1 | Q03591 | 275 |
| IQCF2 | UNC5CL | Q8IV45 | 270 |
| IQCF2 | MASP2 | O00187 | 256 |
| IQCF2 | SLC22A2 | O15244 | 253 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IQCF2 | LONRF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LONRF1 | IQCF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | GRN | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | PRPS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | KIF1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | RNF11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCF2 | TRAFD1 | psi-mi:“MI:0914”(association) | 0.350 |
| IQCF2 | CETN3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (24): IQCF2 (Two-hybrid), IQCF2 (Affinity Capture-MS), STIL (Affinity Capture-MS), PASK (Affinity Capture-MS), TRAFD1 (Affinity Capture-MS), CST8 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), TAX1BP1 (Affinity Capture-MS), PRKAR1B (Affinity Capture-MS), AKAP11 (Affinity Capture-MS), RNF31 (Affinity Capture-MS), TUBA1A (Affinity Capture-MS), BIRC6 (Affinity Capture-MS), MDM2 (Affinity Capture-MS), HSPA8 (Affinity Capture-MS)
ESM2 similar proteins: A1A5Q7, A4D126, A4II32, A6NCI4, A8K8P3, A8MTL0, A8MYZ5, A9CB34, E0CYC6, F1QWK4, O14772, O15554, O89109, P0C7M6, P0C8N6, Q05AA6, Q08CB3, Q13474, Q1HAQ0, Q1LWG4, Q2M2U5, Q32KU4, Q3SYS7, Q3TFD2, Q3UVV9, Q4AC99, Q5I0I4, Q5R796, Q5RFS1, Q8BHD4, Q8BP00, Q8BPW0, Q8CB65, Q8CHT6, Q8IXL9, Q8K2I9, Q8N0W5, Q8N6M8, Q8NEA4, Q8NF37
Diamond homologs: A8MTL0, A8MYZ5, P0C7M6, Q2M2U5, Q32KU4, Q3SYS7, Q6AXX0, Q8IXL9, Q8N6M8, Q9D498, Q9D9K8, Q9DAL7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
373 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:51861947:CAAG:C | donor_loss | 0.9900 |
| 3:51861948:AAGG:A | donor_loss | 0.9900 |
| 3:51861949:AGGT:A | donor_loss | 0.9900 |
| 3:51861950:GGT:G | donor_loss | 0.9900 |
| 3:51861951:G:T | donor_loss | 0.9900 |
| 3:51861952:T:A | donor_loss | 0.9900 |
| 3:51862982:CCTA:C | acceptor_loss | 0.9700 |
| 3:51862983:CTAG:C | acceptor_loss | 0.9700 |
| 3:51862984:TA:T | acceptor_loss | 0.9700 |
| 3:51862986:G:GC | acceptor_loss | 0.9700 |
| 3:51862985:A:AG | acceptor_gain | 0.9600 |
| 3:51862986:G:GG | acceptor_gain | 0.9600 |
| 3:51862986:GGAA:G | acceptor_gain | 0.9500 |
| 3:51862986:GGAAA:G | acceptor_gain | 0.9500 |
| 3:51862854:C:A | donor_gain | 0.9400 |
| 3:51862885:G:GT | donor_gain | 0.9400 |
| 3:51861951:G:GG | donor_gain | 0.9300 |
| 3:51862822:G:GT | donor_gain | 0.9100 |
| 3:51862852:G:GG | donor_gain | 0.9100 |
| 3:51862986:GGA:G | acceptor_gain | 0.9100 |
| 3:51862984:TAGGA:T | acceptor_gain | 0.8900 |
| 3:51862985:AG:A | acceptor_gain | 0.8900 |
| 3:51862985:AGGAA:A | acceptor_gain | 0.8900 |
| 3:51862986:GG:G | acceptor_gain | 0.8900 |
| 3:51862851:A:AG | donor_gain | 0.8800 |
| 3:51862823:A:T | donor_gain | 0.8700 |
| 3:51861844:A:AG | acceptor_gain | 0.8600 |
| 3:51861778:T:TA | donor_gain | 0.8500 |
| 3:51861779:A:AA | donor_gain | 0.8500 |
| 3:51861888:G:GC | acceptor_gain | 0.8400 |
AlphaMissense
1068 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:51863035:T:A | W54R | 0.923 |
| 3:51863035:T:C | W54R | 0.923 |
| 3:51863344:T:C | F157L | 0.923 |
| 3:51863346:C:A | F157L | 0.923 |
| 3:51863346:C:G | F157L | 0.923 |
| 3:51863104:T:A | W77R | 0.917 |
| 3:51863104:T:C | W77R | 0.917 |
| 3:51863039:G:C | R55P | 0.910 |
| 3:51863211:G:A | M112I | 0.905 |
| 3:51863211:G:C | M112I | 0.905 |
| 3:51863211:G:T | M112I | 0.905 |
| 3:51863108:G:C | R78P | 0.888 |
| 3:51863212:T:A | W113R | 0.885 |
| 3:51863212:T:C | W113R | 0.885 |
| 3:51863207:G:C | R111P | 0.883 |
| 3:51863029:G:C | A52P | 0.882 |
| 3:51863106:G:C | W77C | 0.881 |
| 3:51863106:G:T | W77C | 0.881 |
| 3:51863054:G:C | R60P | 0.873 |
| 3:51863248:G:C | A125P | 0.871 |
| 3:51863032:T:A | W53R | 0.870 |
| 3:51863032:T:C | W53R | 0.870 |
| 3:51863071:G:C | A66P | 0.866 |
| 3:51863028:G:C | Q51H | 0.864 |
| 3:51863028:G:T | Q51H | 0.864 |
| 3:51863041:G:C | G56R | 0.863 |
| 3:51863345:T:C | F157S | 0.859 |
| 3:51863053:C:A | R60S | 0.857 |
| 3:51863196:G:C | Q107H | 0.857 |
| 3:51863196:G:T | Q107H | 0.857 |
dbSNP variants (sampled 300 via entrez): RS1000763602 (3:51861248 C>G,T), RS1001193861 (3:51863625 C>G), RS1003611610 (3:51859985 T>C), RS1003663919 (3:51859684 A>G), RS1004055641 (3:51862619 G>C), RS1004941914 (3:51860863 G>A,T), RS1005056680 (3:51861148 G>A,C), RS1005494552 (3:51862154 C>A), RS1008077072 (3:51861864 G>A), RS1009134106 (3:51860195 T>C), RS1012247898 (3:51860911 G>A), RS1012470623 (3:51860005 G>C), RS1012774607 (3:51861173 G>T), RS1012833287 (3:51860407 C>T), RS1015353811 (3:51862332 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.